The groundbreaking success of the copyright undeniably revolutionized the drug landscape, but betting in companies strongly reliant on off-patent versions presents a complex picture. Although early returns were substantial, the expiration of patents and the check here rise of cheaper alternatives have eroded sales. Consequently, a thorough assessme